The incidence of invasive pneumococcal serotype 3 disease in the Danish population is not reduced by PCV-13 vaccination

Hans-Christian Slotved, Tine Dalby, Zitta Barrella Harboe, Palle Valentiner-Branth, Victoria Fernandez de Casadevante, Laura Espenhain, Kurt Fuursted, Helle Bossen Konradsen

    42 Citationer (Scopus)

    Abstract

    Since 2010, Denmark has included the 13-valent pneumococcal conjugated vaccine (PCV-13) in the childhood immunization programme. However, serotype 3 remains as an important cause of invasive pneumococcal disease (IPD) in Denmark. IPD surveillance data (1999-2016) was used to calculate the incidence and age-distribution of serotype 3 IPD, and the effect of PCV-13 on serotype 3 IPD incidence was examined. The incidence of serotype 3 IPD in the age group below 65 years was 0.51/100,000 pre PCV-13, and 0.45/100,000 post PCV-13. In the group 0-4 years, serotype 3 IPD incidence was 0.28/100,000 pre PCV-13, and 0.16/100,000 post PCV-13. Serotype 3 IPD incidence in the elderly showed a mean of 4.27/100,000 pre PCV-13, and 4.32/100,000 post PCV-13. PCV-13 childhood immunization in Denmark has not lead to a reduction of the incidence of IPD caused by serotype 3. The reason behind this missing effect needs to be investigated further.

    OriginalsprogEngelsk
    TidsskriftHeliyon
    Vol/bind2
    Udgave nummer11
    Sider (fra-til)e00198
    ISSN2405-8440
    DOI
    StatusUdgivet - nov. 2016

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'The incidence of invasive pneumococcal serotype 3 disease in the Danish population is not reduced by PCV-13 vaccination'. Sammen danner de et unikt fingeraftryk.

    Citationsformater